Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567381 · ClinicalTrials.gov registry record · NA
An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program
A NA study of Violence and Recidivism, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT04567381: Completed NA study of Violence and Recidivism, sponsored by Medstar Health Research Institute.
NCT04567381 is a NA study of Violence and Recidivism that has completed, run by Medstar Health Research Institute. The registered enrollment target is 400 participants, below the 4,516-participant average among 19 other Violence trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04567381, a NA study of Violence and Recidivism, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized control trial design to evaluate the effectiveness of a hospital based violence intervention program. Participants will be randomized into a "treatment as usual" group who will receive written referrals for services and an "enhanced services" group who will receive intensive case management over a one year period. Primary outcome will be rate of violent reinjury after enrollment. Follow-up will be for one year.
Primary Outcome
Subsequent violent reinjury
Conditions Studied
Interventions
- OTHER Treatment as Usual
- OTHER Enhanced Services
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT04567381 record still lists
NCT04567381 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 4,516-participant average among 19 other Violence trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Violence appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT04567381 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04567381 about?
NCT04567381 is a clinical study titled "An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program". This is a prospective randomized control trial design to evaluate the effectiveness of a hospital based violence intervention program. Participants will be randomized into a "treatment as usual" group who will receive written referrals for services and an "enhanced services" group who will receive i...
What is the current status of trial NCT04567381?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-08-01. Estimated completion is 2021-10-31.
What conditions does trial NCT04567381 study?
This clinical trial studies the following conditions: Violence, Recidivism.
What interventions are being tested in trial NCT04567381?
The interventions under investigation include: Treatment as Usual (OTHER), Enhanced Services (OTHER).
Who is sponsoring clinical trial NCT04567381?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04567381 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04567381's enrollment target sits among peer trials
400 15th of 19 higher than 5 of 19 other Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evidence-based Family Support Program for Parents and Children in Palestine: a Theory-based Intervention
RECRUITING · NA
-
Preventing Retaliatory Gun Violence in Violently Injured Adults
RECRUITING · NA
-
#ChopViolence/#ChopHIV
RECRUITING · NA
-
A Hospital-based Intervention for Youth Injured Through Violence
RECRUITING · NA
-
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
RECRUITING · NA
-
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI